Group One Trading
LXRX icon

Group One Trading’s Lexicon Pharmaceuticals LXRX Stock Holding History

Group One Trading’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$525K Buy
336,300
+212,800
+172% +$309K ﹤0.01% 3297
2025
Q4 		$142K Sell
123,500
-43,600
-26% -$59.9K ﹤0.01% 4679
2025
Q3 		$226K Sell
167,100
-1,500
-0.9% -$1.7K ﹤0.01% 4557
2025
Q2 		$159K Buy
168,600
+22,900
+16% +$14.8K ﹤0.01% 4560
2025
Q1 		$67.1K Sell
145,700
-42,400
-23% -$26.8K ﹤0.01% 4923
2024
Q4 		$139K Sell
188,100
-675,700
-78% -$814K ﹤0.01% 4239
2024
Q3 		$1.36M Sell
863,800
-433,300
-33% -$772K ﹤0.01% 2050
2024
Q2 		$2.18M Sell
1,297,100
-1,885,100
-59% -$3.38M 0.01% 1376
2024
Q1 		$7.64M Buy
3,182,200
+2,974,800
+1,434% +$6.39M 0.03% 567
2023
Q4 		$317K Sell
207,400
-76,200
-27% -$90.6K ﹤0.01% 3462
2023
Q3 		$309K Buy
283,600
+204,800
+260% +$359K ﹤0.01% 3412
2023
Q2 		$180K Buy
78,800
+72,000
+1,059% +$191K ﹤0.01% 4050
2023
Q1 		$16.5K Sell
6,800
-8,100
-54% -$18.6K ﹤0.01% 5635
2022
Q4 		$28.5K Buy
14,900
+6,200
+71% +$13.2K ﹤0.01% 5380
2022
Q3 		$21K Sell
8,700
-24,400
-74% -$67.5K ﹤0.01% 6039
2022
Q2 		$62K Buy
33,100
+21,500
+185% +$41K ﹤0.01% 5391
2022
Q1 		$24K Sell
11,600
-8,300
-42% -$23K ﹤0.01% 6641
2021
Q4 		$78K Sell
19,900
-76,100
-79% -$370K ﹤0.01% 5948
2021
Q3 		$462K Buy
96,000
+74,500
+347% +$306K ﹤0.01% 4286
2021
Q2 		$99K Sell
21,500
-94,400
-81% -$455K ﹤0.01% 5968
2021
Q1 		$680K Buy
115,900
+44,400
+62% +$307K ﹤0.01% 3674
2020
Q4 		$245K Buy
71,500
+52,300
+272% +$99.8K ﹤0.01% 3910
2020
Q3 		$28K Sell
19,200
-11,900
-38% -$21.2K ﹤0.01% 4977
2020
Q2 		$62K Buy
31,100
+13,200
+74% +$25.9K ﹤0.01% 4224
2020
Q1 		$35K Sell
17,900
-63,200
-78% -$188K ﹤0.01% 3935
2019
Q4 		$337K Buy
81,100
+6,600
+9% +$25.4K ﹤0.01% 2772
2019
Q3 		$224K Buy
74,500
+59,200
+387% +$183K ﹤0.01% 3003
2019
Q2 		$96K Sell
15,300
-100
-0.6% -$599 ﹤0.01% 3378
2019
Q1 		$86K Buy
15,400
+10,400
+208% +$63.2K ﹤0.01% 3275
2018
Q4 		$33K Hold
5,000
– – ﹤0.01% 3765
2018
Q3 		$53K Sell
5,000
-1,100
-18% -$12.6K ﹤0.01% 3943
2018
Q2 		$73K Buy
+6,100
New +$62.4K ﹤0.01% 3738
2017
Q4 		– Sell
-300
Closed -$4K – 5047
2017
Q3 		$4K Sell
300
-14,500
-98% -$214K ﹤0.01% 4538
2017
Q2 		$243K Sell
14,800
-41,100
-74% -$636K ﹤0.01% 2502
2017
Q1 		$802K Buy
55,900
+34,900
+166% +$518K 0.01% 1495
2016
Q4 		$290K Buy
21,000
+11,400
+119% +$183K ﹤0.01% 2161
2016
Q3 		$173K Buy
9,600
+600
+7% +$9.66K ﹤0.01% 2569
2016
Q2 		$129K Sell
9,000
-17,700
-66% -$240K ﹤0.01% 2689
2016
Q1 		$319K Buy
26,700
+1,800
+7% +$18.9K ﹤0.01% 2007
2015
Q4 		$331K Buy
24,900
+23,500
+1,679% +$289K ﹤0.01% 2130
2015
Q3 		$15K Sell
1,400
-1,100
-44% -$12K ﹤0.01% 4155
2015
Q2 		$20K Buy
+2,500
New +$18.4K ﹤0.01% 4026

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Group One Trading's LXRX Position: Q1 2026 in Review

Group One Trading reduced its Lexicon Pharmaceuticals (LXRX) stake by 18% in Q1 2026, selling an estimated $57.1K and leaving 185,006 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #3829.

Group One Trading first reported a position in LXRX in Q3 2015 and has held it in 28 quarters since. The position peaked at $861K in Q3 2017. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Group One Trading held 185,006 shares of Lexicon Pharmaceuticals worth $289K as of Q1 2026.
  • Group One Trading sold 39,302 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $57.1K.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3829 holding.
  • Group One Trading first reported a position in Lexicon Pharmaceuticals in Q3 2015 and has held it in 28 quarters since.
  • Group One Trading's Lexicon Pharmaceuticals position peaked at $861K in Q3 2017.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.